The median progression-free survival period with the drug combination was 11.8 months, twice as long as the 5.9 months achieved with paclitaxel alone.
药物联用的中值无进展存活期为11.8个月,是用单独紫杉醇获得的5.9个月的两倍。
The international team of researchers found that blocking certain proteins stabilised the microtubules and made ovarian cancer cells more sensitive to paclitaxel.
国际研究小组的研究人员发现,阻断某些蛋白质可以稳定微管,使卵巢癌细胞对紫杉醇更敏感。
HA with a specific targeting property could increase the bioavailability of paclitaxel and control the release rate of the drug.
既利用透明质酸对癌细胞的靶向性,提高了紫杉醇的生物利用度,又达到了药物缓释的效果。
Another 54 people did not receive paclitaxel in any form.
另外54人未接受任何形式的紫杉醇。
Objective To evaluate the effect of paclitaxel combined DDP on advanced breast cancer.
目的评价紫杉醇联合顺铂对晚期乳腺癌的治疗作用。
Objective To investigate the efficacy and safety of slow release paclitaxel eluting stents.
目的评价紫杉醇慢速释放支架的近期安全性及效果。
Clinical non cross resistance had been demonstrated between TPT and cisplatin or paclitaxel.
临床试验表明,TPT与顺铂和紫杉醇无交叉耐药性。
All cases received 2 to 6 cycles of chemotherapy based on paclitaxel, with average of 3.11 cycles.
所有病例入院后化疗至少2周期,一般给予2 ~6周期,平均3.11周期,均可评价客观疗效。
The most commonly used anti-proliferative drugs are paclitaxel and rapamycin, and their derivatives.
目前最常用的抗增生药物为紫杉醇和雷帕霉素及其衍生物。
Objective To evaluate the efficiency and toxicity of paclitaxel in patients with advanced malignancies.
目的观察以紫杉类为主的联合化疗方案治疗晚期恶性肿瘤的临床疗效及毒副反应。
To investigate the proliferative effect of paclitaxel against humananaplastic thyroid carcinoma cells (DRO).
观察不同浓度的紫杉醇对人甲状腺未分化癌细胞DRO生长的影响。
Objective To study the ideal method of the renovation in the tissue damage by paclitaxel vascular extravasation.
目的为了探讨紫杉醇静脉注射外渗后局部组织损伤修复的理想方法。
To study the efficacy and tolerance of paclitaxel therapy for metastatic breast cancer with adriamycin resistance.
目的研究紫杉醇治疗阿霉素耐药的晚期乳腺癌的疗效和耐受性。
The invention relates to a mutual prodrug and a preparation method thereof based on paclitaxel and nitrogen mustard.
本发明涉及一种基于紫杉醇-氮芥的协同前药及其制备方法。
Conclusion: the combination of paclitaxel and cisplatin was an effective regimen as neoadjuvant chemotherapy for LAEC.
结论:紫杉醇联合顺铂新辅助化疗方案治疗中晚期食管癌疗效显著。
Objective To explore paclitaxel(PTX) union chemotherapy curative effect and security for breast cancer of later period.
目的探讨紫杉醇(PTX)为主的联合化疗方案治疗晚期乳腺癌的疗效及安全性。
The major challenges we are facing in cancer therapy with paclitaxel (PTX) are the drug resistance and severe side effects.
我们面临的主要挑战是用紫杉醇(ptx)治疗癌症时的抗药性和严重的副作用。
Patients received four courses of chemotherapy with paclitaxel, carboplatin, and etoposide, administered at 3-week intervals.
病人接受四个疗程的紫杉醇、卡铂、依托泊苷化学治疗,每个疗程间隔3周。
Objective: To inspect the effect of activated carbon with different dosage and temperature on quality of paclitaxel injection.
目的:考察活性炭用量和温度对紫杉醇注射液质量的影响。
OBJECTIVE To study the influence of interior gelatinization on the stability of freeze dried liposomes with paclitaxel loaded.
目的制备载紫杉醇内部胶凝化脂质体,考察内部胶凝在冷冻干燥中对脂质体的稳定作用。
Objective To investigate the radiosensitizing enhancement effect of paclitaxel on human adenoid cystic carcinoma ACC 2 line cell.
目的评价紫杉醇对人腺样囊性癌细胞株acc- 2的辐射增敏作用。
Objective: to study the effect and toxicities of China made paclitaxel in the treatment of advanced epithelial ovarian carcinoma.
目的:探讨国产紫杉醇治疗晚期卵巢上皮性癌的疗效及其毒性。
Objective to observe the efficacy and toxicities of paclitaxel combined with DDP in treatment of advanced nasopharyngeal carcinoma.
目的观察紫杉醇联合顺铂治疗远处转移的晚期鼻咽癌的疗效和毒副反应。
OBJECTIVE To study the preparation of paclitaxel entrapped magnetic non ionic surfactant vesicles (tax MNS) and evaluate its quality.
目的:对紫杉醇磁性非离子表面活性剂泡囊的处方和制备工艺进行研究,并评价其质量。
ObjectiveTo observe the effect of oral prednisone to relieve paclitaxel-induced arthralgia and myalgia in patients with ovarian cancer.
目的观察卵巢癌患者化疗时口服强的松对紫杉醇引起的关节痛和肌痛的缓解效果。
Analytical method was developed for the trace analysis of taxanes in crude extraction and identification of the antitumor agent paclitaxel.
建立了一套利用反相高效液相色谱和大气压化学电离质谱联用技术分析红豆杉提取物中微量紫杉烷类化合物的方法。
Revascularization rates were similar with the sirolimus - and paclitaxel-eluting stents in the two trials, at 5.6% versus 5.3%, respectively.
再次血运重建率在西罗莫司和紫杉醇的两个临床试验类似,分别为5.6%和5.3%。
Objective to evaluate the relation of dose intensity and efficacy, toxicity in advanced breast cancer treated with paclitaxel as a single agent.
目的分析单药紫杉醇治疗晚期乳腺癌剂量强度与疗效和毒性的关系。
Objective: to investigate the growth-inhibitory and apoptosis-inducing effect of paclitaxel on human melanoma A375 cell and its mechanism in vitro.
目的:探讨紫杉醇体外抑制人黑色素瘤细胞(A375细胞)增殖及诱导凋亡作用机制。
Objective: to investigate the growth-inhibitory and apoptosis-inducing effect of paclitaxel on human melanoma A375 cell and its mechanism in vitro.
目的:探讨紫杉醇体外抑制人黑色素瘤细胞(A375细胞)增殖及诱导凋亡作用机制。
应用推荐